ADMA BIOLOGICS, INC. — Director's Dealing 2025

Feb 22, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ADMA BIOLOGICS, INC. (ADMA)
CIK: 0001368514
Period of Report: 2025-02-19

Reporting Person: Guiheen Lawrence P. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-19	Common Stock	A	10889	—	Acquired	164830	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-19	Stock Option (right to buy)	$16.07	A	16279	Acquired	2035-02-19	Common Stock (16279)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1000	Indirect

Footnotes

F1: These shares represent restricted stock units ("RSUs") that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the Reporting Person's continued service as of the applicable vesting date.

F2: Includes, as of the transaction date, (i) 10,889 RSUs granted on February 19, 2025 and reported on this Form 4, subject to vesting as set forth in footnote (1); (ii) 12,020 restricted stock units granted on February 26, 2024, which will vest fully on February 26, 2025, subject to the Reporting Person's continued service as of such vesting date; and (iii) 141,921 shares of common stock owned by the Reporting Person.

F3: These shares are owned by the Guiheen Trust, of which the Reporting Person serves as a joint trustee.

F4: The options vest in 12 equal monthly installments, becoming fully vested on the one-year anniversary of the date of grant.